Frontotemporal dementia: latest evidence and clinical implications
JJ Young, M Lavakumar, D Tampi… - Therapeutic …, 2018 - journals.sagepub.com
Background: Frontotemporal dementia (FTD) describes a cluster of neurocognitive
syndromes that present with impairment of executive functioning, changes in behavior, and …
syndromes that present with impairment of executive functioning, changes in behavior, and …
Frontotemporal dementia: from molecular mechanisms to therapy
C Haass, M Neumann - Journal of Neurochemistry, 2016 - Wiley Online Library
Frontotemporal dementia (FTD) is a heterogeneous clinical syndrome characterized by
frontotemporal lobar degeneration (FTLD). Neuropathologically, FTLD is characterized by …
frontotemporal lobar degeneration (FTLD). Neuropathologically, FTLD is characterized by …
From frontotemporal lobar degeneration pathology to frontotemporal lobar degeneration biomarkers
CM Hales, WT Hu - International review of psychiatry, 2013 - Taylor & Francis
Frontotemporal dementia (FTD) is an increasingly recognized cause of dementia. This
review discusses the different FTD clinical syndromes and frontotemporal lobar …
review discusses the different FTD clinical syndromes and frontotemporal lobar …
Neuropathologic subtypes of frontotemporal lobar degeneration
M Tada, A Kakita - Brain and Nerve= Shinkei Kenkyu no Shinpo, 2018 - europepmc.org
Frontotemporal lobar degeneration (FTLD) is a heterogeneous disease entity encompassing
a wide variety of histopathological features and genetic backgrounds. The last two decades …
a wide variety of histopathological features and genetic backgrounds. The last two decades …
Genetic forms of frontotemporal lobar degeneration: current diagnostic approach and new directions in therapeutic strategies
L Sellami, D Saracino, I Le Ber - Revue neurologique, 2020 - Elsevier
Recent advances in the genetics of neurodegenerative diseases have substantially
improved our knowledge about the genetic causes of frontotemporal lobar degeneration …
improved our knowledge about the genetic causes of frontotemporal lobar degeneration …
[引用][C] PL‐05‐01: The pathological mechanisms leading to neurodegeneration and cell death in frontotemporal dementia
M Neumann - Alzheimer's & Dementia, 2011 - Wiley Online Library
Background Frontotemporal dementia is the second most common cause of presenile
dementia and is a clinically, genetically and pathologically heterogeneous syndrome. The …
dementia and is a clinically, genetically and pathologically heterogeneous syndrome. The …
Genetics of frontotemporal lobar degeneration: an up-date and diagnosis algorithm
I Le Ber - Revue neurologique, 2013 - Elsevier
The last decade marked a turning point in the knowledge of frontotemporal lobar
degenerations (FTLD). Major discoveries were made with the identification of TDP-43 and …
degenerations (FTLD). Major discoveries were made with the identification of TDP-43 and …
Frontotemporal dementia.
M Memel, JH Kramer, D Chen - 2023 - psycnet.apa.org
Frontotemporal dementia (FTD) encompasses a heterogeneous group of clinical syndromes
marked by progressive neurodegeneration in frontal and temporal brain regions. FTD …
marked by progressive neurodegeneration in frontal and temporal brain regions. FTD …
[HTML][HTML] Frontotemporal lobar degeneration: a clinical approach
E Karageorgiou, BL Miller - Seminars in neurology, 2014 - thieme-connect.com
In this review, the authors outline a clinical approach to frontotemporal lobar degeneration
(FTLD), a term coined to describe a pathology associated with atrophy of the frontal and …
(FTLD), a term coined to describe a pathology associated with atrophy of the frontal and …
[HTML][HTML] Deficient neurotransmitter systems and synaptic function in frontotemporal lobar degeneration—Insights into disease mechanisms and current therapeutic …
N Huber, S Korhonen, D Hoffmann, S Leskelä… - Molecular …, 2022 - nature.com
Frontotemporal lobar degeneration (FTLD) comprises a heterogenous group of fatal
neurodegenerative diseases and, to date, no validated diagnostic or prognostic biomarkers …
neurodegenerative diseases and, to date, no validated diagnostic or prognostic biomarkers …